🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Influenza virus is a significant pathogen in pediatric solid organ transpla...
Status
Recruiting
Location
Stanford University
Start Date
2024-09-26
Trial ID
NCT05947071
Lung allograft recipients have a higher burden of influenza disease and gre...
Status
Recruiting
Location
Vanderbilt University Medical Center
Start Date
2022-11-08
Trial ID
NCT05215327
This EPSS will determine the vaccinee reporting rates (RRs) of suspected AD...
Status
Completed
Location
Investigational Site Number : 2460001
Start Date
2023-10-02
Trial ID
NCT06059456
Treatments Being Tested
The purpose of this study is to evaluate the safety and immunogenicity of G...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-04-29
Trial ID
NCT02369341
Treatments Being Tested
Influenza is an acute respiratory disease caused by influenza viruses. Ther...
Status
Completed
Location
Guanyun County Center for Disease Control and Prevention
Start Date
2016-01
Trial ID
NCT02710409
Treatments Being Tested
To explore the immunogenicity and safety of quadrivalent split influenza vi...
Status
Unknown
Location
Yangchun Center for Disease Control and Prevention
Start Date
2022-03-02
Trial ID
NCT05389137
Treatments Being Tested
The goal of this \[To evaluate the immunogenicity and safety of 1 - and 2-d...
Status
Completed
Location
Kou Zengqiang
Start Date
2021-09-15
Trial ID
NCT06095947
Treatments Being Tested
This study will evaluate the relative vaccine effectiveness of quadrivalent...
Status
Recruiting
Location
Kaiser Permanente Northern California (entire region)
Start Date
2023-08-17
Trial ID
NCT06029933
Primary Objective: To demonstrate the superior relative effectiveness of Q...
Status
Terminated
Location
Investigational Site Number 2469999
Start Date
2019-11-04
Trial ID
NCT04137887
The goal of this clinical trial is to assess tolerability, safety and immun...
Status
Completed
Location
Federally Funded Healthcare Institution Primary Healthcare Unit No. 163,of Federal Medical and Biologic Agency (FFHI PHU No. 163, FMBA of Russia)
Start Date
2020-10-06
Trial ID
NCT05869201